July 24, 2020
Venock Expands Design for Large-Bore Venous Closure System in Development
July 24, 2020—Venock, Inc. announced that it has expanded the design of its large-bore venous closure system to also be effective at high-pressure conditions for closure of large-bore arterial perforations.
The vascular closure device is designed to close very large perforations that can be as big as the diameter of the vein or the artery. The company advised that the Venock system is not currently approved for sale or investigational use.
Venock is developing a vascular closure system for large-bore punctures in vessels after transvenous catheter-based therapies (such as atrial ablations and leadless pacemaker implantations) and various structural heart therapies (such as mitral and tricuspid valve repair and replacement). Additionally, the Venock device will close large-bore arterial access sites left by percutaneous aortic valve implantations, catheter-based ventricular assist devices, and pulmonary assist systems.
Venock is a privately held United States medical device company headquartered in New York, New York, with the subsidiary Venock Medical GmbH in Munich, Germany.
“We invested a great deal of effort to expand our large-bore venous closure technology to include closure of large-bore arterial perforations,” stated Venock CEO Terry Barnes in the company announcement. “Venock is developing the first universal large-bore closure device for veins and arteries. We will plan our first investigational device exemption clinical study to enroll 120 patients with large-bore venous interventional procedures in 10 clinical centers with a 30-day follow-up.”